فنلافاكسين (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "فنلافاكسين" in Arabic language version.

refsWebsite

Global rank Arabic rank

26nih.gov

4^th place

6^th place

20doi.org

2^nd place

5^th place

12web.archive.org

1^st place

7issn.org

57^th place

1,629^th place

7wikidata.org

43^rd place

2^nd place

7semanticscholar.org

11^th place

86^th place

4archive.org

6^th place

3^rd place

2tga.gov.au

3,984^th place

2,181^st place

2clincalc.com

3,912^th place

2,538^th place

1tandfonline.com

507^th place

549^th place

1wiley.com

222^nd place

221^st place

1ebi.ac.uk

5,849^th place

872^nd place

1drugs.com

399^th place

241^st place

1mayoclinic.org

1,610^th place

389^th place

1mayoclinic.com

3,634^th place

4,268^th place

1stanford.edu

179^th place

237^th place

1fda.gov

447^th place

393^rd place

1psychiatryonline.org

4,032^nd place

2,609^th place

archive.org

Grothe DR، Scheckner B، Albano D (مايو 2004). "Treatment of pain syndromes with venlafaxine". Pharmacotherapy. ج. 24 ع. 5: 621–9. DOI:10.1592/phco.24.6.621.34748. PMID:15162896. S2CID:28187627.
Schober CE، Ansani NT (2003). "Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. ج. 37 ع. 11: 1703–7. DOI:10.1345/aph.1C483. PMID:14565812. S2CID:45334784.
Phelps NJ، Cates ME (يناير 2005). "The role of venlafaxine in the treatment of obsessive-compulsive disorder". Annals of Pharmacotherapy. ج. 39 ع. 1: 136–40. DOI:10.1345/aph.1E362. PMID:15585743. S2CID:30973410.
The Maudsley Prescribing Guidelines in Psychiatry (ط. illustrated). John Wiley & Sons. 2012. ISBN:978-0-470-97948-8.

clincalc.com

"Venlafaxine - Drug Usage Statistics". ClinCalc. مؤرشف من الأصل في 2021-11-29. اطلع عليه بتاريخ 2021-10-16.
"The Top 300 of 2019". ClinCalc. مؤرشف من الأصل في 2021-12-17. اطلع عليه بتاريخ 2021-10-16.

doi.org

Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
C. J. Elko; J. L. Burgess; W. O. Robertson (1 Jan 1998). "Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction". Journal of Toxicology: Clinical Toxicology (بالإنجليزية). 36 (3): 195–203. DOI:10.3109/15563659809028939. ISSN:0731-3810. PMID:9656974. QID:Q74764031.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002
Grothe DR، Scheckner B، Albano D (مايو 2004). "Treatment of pain syndromes with venlafaxine". Pharmacotherapy. ج. 24 ع. 5: 621–9. DOI:10.1592/phco.24.6.621.34748. PMID:15162896. S2CID:28187627.
Schober CE، Ansani NT (2003). "Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. ج. 37 ع. 11: 1703–7. DOI:10.1345/aph.1C483. PMID:14565812. S2CID:45334784.
Phelps NJ، Cates ME (يناير 2005). "The role of venlafaxine in the treatment of obsessive-compulsive disorder". Annals of Pharmacotherapy. ج. 39 ع. 1: 136–40. DOI:10.1345/aph.1E362. PMID:15585743. S2CID:30973410.
Ghanizadeh A، Freeman RD، Berk M (مارس 2013). "Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials". Reviews on Recent Clinical Trials. ج. 8 ع. 1: 2–8. DOI:10.2174/1574887111308010002. PMID:23157376.
Courtney DB (2004). "Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials". Canadian Journal of Psychiatry. ج. 49 ع. 8: 557–63. DOI:10.1177/070674370404900807. PMID:15453105.
Cipriani A، Furukawa TA، Salanti G، Chaimani A، Atkinson LZ، Ogawa Y، وآخرون (أبريل 2018). "Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis". Lancet. ج. 391 ع. 10128: 1357–1366. DOI:10.1016/S0140-6736(17)32802-7. PMC:5889788. PMID:29477251.
Thase، Michael؛ Asami، Yuko؛ Wajsbrot، Dalia؛ Dorries، Kathleen؛ Boucher، Matthieu؛ Pappadopulos، Elizabeth (28 November 2016). "A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. ج. 33 ع. 2: 317–326. DOI:10.1080/03007995.2016.1255185. ISSN:0300-7995. PMID:27794623. S2CID:4394404. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |سنة= لا يطابق |تاريخ= (مساعدة)
Cipriani A، Furukawa TA، Salanti G، Geddes JR، Higgins JP، Churchill R، وآخرون (فبراير 2009). "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. ج. 373 ع. 9665: 746–58. DOI:10.1016/S0140-6736(09)60046-5. PMID:19185342. S2CID:35858125.
Furukawa، Toshi A.؛ Cipriani، Andrea؛ Cowen، Philip J.؛ Leucht، Stefan؛ Egger، Matthias؛ Salanti، Georgia (2020). "Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis". Focus (American Psychiatric Publishing). American Psychiatric Association Publishing. ج. 18 ع. 2: 211–219. DOI:10.1176/appi.focus.18204. ISSN:1541-4094. PMC:7587875. PMID:33343239.
Tiihonen J، Lönnqvist J، Wahlbeck K، Klaukka T، Tanskanen A، Haukka J (ديسمبر 2006). "Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort". Archives of General Psychiatry. ج. 63 ع. 12: 1358–67. DOI:10.1001/archpsyc.63.12.1358. PMID:17146010.
Gibbons RD، Brown CH، Hur K، Davis J، Mann JJ (يونيو 2012). "Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine". Arch. Gen. Psychiatry. ج. 69 ع. 6: 580–7. DOI:10.1001/archgenpsychiatry.2011.2048. PMC:3367101. PMID:22309973.
Rubino A، Roskell N، Tennis P، Mines D، Weich S، Andrews E (2007). "Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study". British Medical Journal. ج. 334 ع. 7587: 242. DOI:10.1136/bmj.39041.445104.BE. PMC:1790752. PMID:17164297.
Emslie GJ، Findling RL، Yeung PP، Kunz NR، Li Y (2007). "Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials". Journal of the American Academy of Child and Adolescent Psychiatry. ج. 46 ع. 4: 479–88. DOI:10.1097/chi.0b013e31802f5f03. PMID:17420682. S2CID:9187105. مؤرشف من الأصل في 2021-04-28.
Brent DA، Emslie GJ، Clarke GN، Asarnow J، Spirito A، Ritz L، Vitiello B، Iyengar S، Birmaher B، Ryan ND، Zelazny J، Onorato M، Kennard B، Mayes TL، Debar LL، McCracken JT، Strober M، Suddath R، Leonard H، Porta G، Keller MB (أبريل 2009). "Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study" (PDF). The American Journal of Psychiatry. ج. 166 ع. 4: 418–26. DOI:10.1176/appi.ajp.2008.08070976. PMC:3593721. PMID:19223438. مؤرشف من الأصل (PDF) في 2013-12-19.

drugs.com

"Venlafaxine Hydrochloride Monograph for Professionals". Drugs.com. AHFS. مؤرشف من الأصل في 2020-11-27. اطلع عليه بتاريخ 2018-12-24.

ebi.ac.uk

venlafaxine، معهد المعلوماتية الحيوية الأوروبي، QID:Q902623

fda.gov

"Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee" (PDF). Food and Drug Administration: Center for Drug Evaluation and Research. 16 نوفمبر 2006. مؤرشف (PDF) من الأصل في 2007-03-16. اطلع عليه بتاريخ 2007-06-20.

issn.org

portal.issn.org

Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
C. J. Elko; J. L. Burgess; W. O. Robertson (1 Jan 1998). "Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction". Journal of Toxicology: Clinical Toxicology (بالإنجليزية). 36 (3): 195–203. DOI:10.3109/15563659809028939. ISSN:0731-3810. PMID:9656974. QID:Q74764031.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Thase، Michael؛ Asami، Yuko؛ Wajsbrot، Dalia؛ Dorries، Kathleen؛ Boucher، Matthieu؛ Pappadopulos، Elizabeth (28 November 2016). "A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. ج. 33 ع. 2: 317–326. DOI:10.1080/03007995.2016.1255185. ISSN:0300-7995. PMID:27794623. S2CID:4394404. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |سنة= لا يطابق |تاريخ= (مساعدة)
Furukawa، Toshi A.؛ Cipriani، Andrea؛ Cowen، Philip J.؛ Leucht، Stefan؛ Egger، Matthias؛ Salanti، Georgia (2020). "Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis". Focus (American Psychiatric Publishing). American Psychiatric Association Publishing. ج. 18 ع. 2: 211–219. DOI:10.1176/appi.focus.18204. ISSN:1541-4094. PMC:7587875. PMID:33343239.

mayoclinic.com

Mayo Clinic staff (2005). "Beyond hormone therapy: Other medicines may help". Hot flashes: Ease the discomfort of menopause. Mayo Clinic. مؤرشف من الأصل في 2005-02-25. اطلع عليه بتاريخ 2005-08-19.

mayoclinic.org

"Antidepressants: Another weapon against chronic pain". Mayo Clinic. مؤرشف من الأصل في 2021-10-26. اطلع عليه بتاريخ 2020-01-25.

nih.gov

pubmed.ncbi.nlm.nih.gov

Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
C. J. Elko; J. L. Burgess; W. O. Robertson (1 Jan 1998). "Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction". Journal of Toxicology: Clinical Toxicology (بالإنجليزية). 36 (3): 195–203. DOI:10.3109/15563659809028939. ISSN:0731-3810. PMID:9656974. QID:Q74764031.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Grothe DR، Scheckner B، Albano D (مايو 2004). "Treatment of pain syndromes with venlafaxine". Pharmacotherapy. ج. 24 ع. 5: 621–9. DOI:10.1592/phco.24.6.621.34748. PMID:15162896. S2CID:28187627.
Schober CE، Ansani NT (2003). "Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. ج. 37 ع. 11: 1703–7. DOI:10.1345/aph.1C483. PMID:14565812. S2CID:45334784.
Phelps NJ، Cates ME (يناير 2005). "The role of venlafaxine in the treatment of obsessive-compulsive disorder". Annals of Pharmacotherapy. ج. 39 ع. 1: 136–40. DOI:10.1345/aph.1E362. PMID:15585743. S2CID:30973410.
Ghanizadeh A، Freeman RD، Berk M (مارس 2013). "Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials". Reviews on Recent Clinical Trials. ج. 8 ع. 1: 2–8. DOI:10.2174/1574887111308010002. PMID:23157376.
Courtney DB (2004). "Selective serotonin reuptake inhibitor and venlafaxine use in children and adolescents with major depressive disorder: a systematic review of published randomized controlled trials". Canadian Journal of Psychiatry. ج. 49 ع. 8: 557–63. DOI:10.1177/070674370404900807. PMID:15453105.
Cipriani A، Furukawa TA، Salanti G، Chaimani A، Atkinson LZ، Ogawa Y، وآخرون (أبريل 2018). "Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis". Lancet. ج. 391 ع. 10128: 1357–1366. DOI:10.1016/S0140-6736(17)32802-7. PMC:5889788. PMID:29477251.
Thase، Michael؛ Asami، Yuko؛ Wajsbrot، Dalia؛ Dorries، Kathleen؛ Boucher، Matthieu؛ Pappadopulos، Elizabeth (28 November 2016). "A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. ج. 33 ع. 2: 317–326. DOI:10.1080/03007995.2016.1255185. ISSN:0300-7995. PMID:27794623. S2CID:4394404. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |سنة= لا يطابق |تاريخ= (مساعدة)
Cipriani A، Furukawa TA، Salanti G، Geddes JR، Higgins JP، Churchill R، وآخرون (فبراير 2009). "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. ج. 373 ع. 9665: 746–58. DOI:10.1016/S0140-6736(09)60046-5. PMID:19185342. S2CID:35858125.
Furukawa، Toshi A.؛ Cipriani، Andrea؛ Cowen، Philip J.؛ Leucht، Stefan؛ Egger، Matthias؛ Salanti، Georgia (2020). "Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis". Focus (American Psychiatric Publishing). American Psychiatric Association Publishing. ج. 18 ع. 2: 211–219. DOI:10.1176/appi.focus.18204. ISSN:1541-4094. PMC:7587875. PMID:33343239.
Tiihonen J، Lönnqvist J، Wahlbeck K، Klaukka T، Tanskanen A، Haukka J (ديسمبر 2006). "Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort". Archives of General Psychiatry. ج. 63 ع. 12: 1358–67. DOI:10.1001/archpsyc.63.12.1358. PMID:17146010.
Gibbons RD، Brown CH، Hur K، Davis J، Mann JJ (يونيو 2012). "Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine". Arch. Gen. Psychiatry. ج. 69 ع. 6: 580–7. DOI:10.1001/archgenpsychiatry.2011.2048. PMC:3367101. PMID:22309973.
Rubino A، Roskell N، Tennis P، Mines D، Weich S، Andrews E (2007). "Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study". British Medical Journal. ج. 334 ع. 7587: 242. DOI:10.1136/bmj.39041.445104.BE. PMC:1790752. PMID:17164297.
Emslie GJ، Findling RL، Yeung PP، Kunz NR، Li Y (2007). "Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials". Journal of the American Academy of Child and Adolescent Psychiatry. ج. 46 ع. 4: 479–88. DOI:10.1097/chi.0b013e31802f5f03. PMID:17420682. S2CID:9187105. مؤرشف من الأصل في 2021-04-28.
Brent DA، Emslie GJ، Clarke GN، Asarnow J، Spirito A، Ritz L، Vitiello B، Iyengar S، Birmaher B، Ryan ND، Zelazny J، Onorato M، Kennard B، Mayes TL، Debar LL، McCracken JT، Strober M، Suddath R، Leonard H، Porta G، Keller MB (أبريل 2009). "Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study" (PDF). The American Journal of Psychiatry. ج. 166 ع. 4: 418–26. DOI:10.1176/appi.ajp.2008.08070976. PMC:3593721. PMID:19223438. مؤرشف من الأصل (PDF) في 2013-12-19.

ncbi.nlm.nih.gov

Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
Cipriani A، Furukawa TA، Salanti G، Chaimani A، Atkinson LZ، Ogawa Y، وآخرون (أبريل 2018). "Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis". Lancet. ج. 391 ع. 10128: 1357–1366. DOI:10.1016/S0140-6736(17)32802-7. PMC:5889788. PMID:29477251.
Furukawa، Toshi A.؛ Cipriani، Andrea؛ Cowen، Philip J.؛ Leucht، Stefan؛ Egger، Matthias؛ Salanti، Georgia (2020). "Optimal Dose of Selective Serotonin Reuptake Inhibitors, Venlafaxine, and Mirtazapine in Major Depression: A Systematic Review and Dose-Response Meta-Analysis". Focus (American Psychiatric Publishing). American Psychiatric Association Publishing. ج. 18 ع. 2: 211–219. DOI:10.1176/appi.focus.18204. ISSN:1541-4094. PMC:7587875. PMID:33343239.
Gibbons RD، Brown CH، Hur K، Davis J، Mann JJ (يونيو 2012). "Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine". Arch. Gen. Psychiatry. ج. 69 ع. 6: 580–7. DOI:10.1001/archgenpsychiatry.2011.2048. PMC:3367101. PMID:22309973.
Rubino A، Roskell N، Tennis P، Mines D، Weich S، Andrews E (2007). "Risk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort study". British Medical Journal. ج. 334 ع. 7587: 242. DOI:10.1136/bmj.39041.445104.BE. PMC:1790752. PMID:17164297.
Brent DA، Emslie GJ، Clarke GN، Asarnow J، Spirito A، Ritz L، Vitiello B، Iyengar S، Birmaher B، Ryan ND، Zelazny J، Onorato M، Kennard B، Mayes TL، Debar LL، McCracken JT، Strober M، Suddath R، Leonard H، Porta G، Keller MB (أبريل 2009). "Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study" (PDF). The American Journal of Psychiatry. ج. 166 ع. 4: 418–26. DOI:10.1176/appi.ajp.2008.08070976. PMC:3593721. PMID:19223438. مؤرشف من الأصل (PDF) في 2013-12-19.

dailymed.nlm.nih.gov

"VENLAFAXINE (venlafaxine hydrochloride) tablet [Aurobindo Pharma Limited]". DailyMed. Aurobindo Pharma Limited. فبراير 2013. مؤرشف من الأصل في 2013-11-05. اطلع عليه بتاريخ 2013-11-06.

psychiatryonline.org

ajp.psychiatryonline.org

Brent DA، Emslie GJ، Clarke GN، Asarnow J، Spirito A، Ritz L، Vitiello B، Iyengar S، Birmaher B، Ryan ND، Zelazny J، Onorato M، Kennard B، Mayes TL، Debar LL، McCracken JT، Strober M، Suddath R، Leonard H، Porta G، Keller MB (أبريل 2009). "Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study" (PDF). The American Journal of Psychiatry. ج. 166 ع. 4: 418–26. DOI:10.1176/appi.ajp.2008.08070976. PMC:3593721. PMID:19223438. مؤرشف من الأصل (PDF) في 2013-12-19.

semanticscholar.org

api.semanticscholar.org

Grothe DR، Scheckner B، Albano D (مايو 2004). "Treatment of pain syndromes with venlafaxine". Pharmacotherapy. ج. 24 ع. 5: 621–9. DOI:10.1592/phco.24.6.621.34748. PMID:15162896. S2CID:28187627.
Schober CE، Ansani NT (2003). "Venlafaxine hydrochloride for the treatment of hot flashes". The Annals of Pharmacotherapy. ج. 37 ع. 11: 1703–7. DOI:10.1345/aph.1C483. PMID:14565812. S2CID:45334784.
Phelps NJ، Cates ME (يناير 2005). "The role of venlafaxine in the treatment of obsessive-compulsive disorder". Annals of Pharmacotherapy. ج. 39 ع. 1: 136–40. DOI:10.1345/aph.1E362. PMID:15585743. S2CID:30973410.
Thase، Michael؛ Asami، Yuko؛ Wajsbrot، Dalia؛ Dorries، Kathleen؛ Boucher، Matthieu؛ Pappadopulos، Elizabeth (28 November 2016). "A meta-analysis of the efficacy of venlafaxine extended release 75–225 mg/day for the treatment of major depressive disorder". Current Medical Research and Opinion. Informa UK Limited. ج. 33 ع. 2: 317–326. DOI:10.1080/03007995.2016.1255185. ISSN:0300-7995. PMID:27794623. S2CID:4394404. {{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |سنة= لا يطابق |تاريخ= (مساعدة)
Cipriani A، Furukawa TA، Salanti G، Geddes JR، Higgins JP، Churchill R، وآخرون (فبراير 2009). "Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis". Lancet. ج. 373 ع. 9665: 746–58. DOI:10.1016/S0140-6736(09)60046-5. PMID:19185342. S2CID:35858125.
Emslie GJ، Findling RL، Yeung PP، Kunz NR، Li Y (2007). "Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials". Journal of the American Academy of Child and Adolescent Psychiatry. ج. 46 ع. 4: 479–88. DOI:10.1097/chi.0b013e31802f5f03. PMID:17420682. S2CID:9187105. مؤرشف من الأصل في 2021-04-28.

semanticscholar.org

Emslie GJ، Findling RL، Yeung PP، Kunz NR، Li Y (2007). "Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials". Journal of the American Academy of Child and Adolescent Psychiatry. ج. 46 ع. 4: 479–88. DOI:10.1097/chi.0b013e31802f5f03. PMID:17420682. S2CID:9187105. مؤرشف من الأصل في 2021-04-28.

stanford.edu

med.stanford.edu

"Medications". Stanford University School of Medicine, Center for Narcolepsy. 7 فبراير 2003. مؤرشف من الأصل في 2007-08-21. اطلع عليه بتاريخ 2007-09-03.

tandfonline.com

C. J. Elko; J. L. Burgess; W. O. Robertson (1 Jan 1998). "Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction". Journal of Toxicology: Clinical Toxicology (بالإنجليزية). 36 (3): 195–203. DOI:10.3109/15563659809028939. ISSN:0731-3810. PMID:9656974. QID:Q74764031.

tga.gov.au

ebs.tga.gov.au

"APO-VENLAFAXINE XR CAPSULES". TGA eBusiness Services. Macquarie Park, NSW: Apotex Pty Ltd. 13 أبريل 2012. مؤرشف من الأصل (PDF) في 2018-04-19. اطلع عليه بتاريخ 2013-11-06.
"Efexor-XR (venlafaxine hydrochloride)". TGA eBS. مؤرشف من الأصل (PDF) في 2020-11-11. اطلع عليه بتاريخ 2021-05-11.

web.archive.org

"APO-VENLAFAXINE XR CAPSULES". TGA eBusiness Services. Macquarie Park, NSW: Apotex Pty Ltd. 13 أبريل 2012. مؤرشف من الأصل (PDF) في 2018-04-19. اطلع عليه بتاريخ 2013-11-06.
"VENLAFAXINE (venlafaxine hydrochloride) tablet [Aurobindo Pharma Limited]". DailyMed. Aurobindo Pharma Limited. فبراير 2013. مؤرشف من الأصل في 2013-11-05. اطلع عليه بتاريخ 2013-11-06.
"Venlafaxine Hydrochloride Monograph for Professionals". Drugs.com. AHFS. مؤرشف من الأصل في 2020-11-27. اطلع عليه بتاريخ 2018-12-24.
"Antidepressants: Another weapon against chronic pain". Mayo Clinic. مؤرشف من الأصل في 2021-10-26. اطلع عليه بتاريخ 2020-01-25.
"Venlafaxine - Drug Usage Statistics". ClinCalc. مؤرشف من الأصل في 2021-11-29. اطلع عليه بتاريخ 2021-10-16.
"The Top 300 of 2019". ClinCalc. مؤرشف من الأصل في 2021-12-17. اطلع عليه بتاريخ 2021-10-16.
Mayo Clinic staff (2005). "Beyond hormone therapy: Other medicines may help". Hot flashes: Ease the discomfort of menopause. Mayo Clinic. مؤرشف من الأصل في 2005-02-25. اطلع عليه بتاريخ 2005-08-19.
"Medications". Stanford University School of Medicine, Center for Narcolepsy. 7 فبراير 2003. مؤرشف من الأصل في 2007-08-21. اطلع عليه بتاريخ 2007-09-03.
"Efexor-XR (venlafaxine hydrochloride)". TGA eBS. مؤرشف من الأصل (PDF) في 2020-11-11. اطلع عليه بتاريخ 2021-05-11.
"Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee" (PDF). Food and Drug Administration: Center for Drug Evaluation and Research. 16 نوفمبر 2006. مؤرشف (PDF) من الأصل في 2007-03-16. اطلع عليه بتاريخ 2007-06-20.
Emslie GJ، Findling RL، Yeung PP، Kunz NR، Li Y (2007). "Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials". Journal of the American Academy of Child and Adolescent Psychiatry. ج. 46 ع. 4: 479–88. DOI:10.1097/chi.0b013e31802f5f03. PMID:17420682. S2CID:9187105. مؤرشف من الأصل في 2021-04-28.
Brent DA، Emslie GJ، Clarke GN، Asarnow J، Spirito A، Ritz L، Vitiello B، Iyengar S، Birmaher B، Ryan ND، Zelazny J، Onorato M، Kennard B، Mayes TL، Debar LL، McCracken JT، Strober M، Suddath R، Leonard H، Porta G، Keller MB (أبريل 2009). "Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study" (PDF). The American Journal of Psychiatry. ج. 166 ع. 4: 418–26. DOI:10.1176/appi.ajp.2008.08070976. PMC:3593721. PMID:19223438. مؤرشف من الأصل (PDF) في 2013-12-19.

wikidata.org

Shobha Phansalkar; Amrita A Desai; Douglas Bell; Eileen Yoshida; John Doole; Melissa Czochanski; Blackford Middleton; David W Bates (26 Apr 2012). "High-priority drug-drug interactions for use in electronic health records". Journal of the American Medical Informatics Association (بالإنجليزية). 19 (5): 735–743. DOI:10.1136/AMIAJNL-2011-000612. ISSN:1067-5027. PMC:3422823. PMID:22539083. QID:Q17505343.
C. J. Elko; J. L. Burgess; W. O. Robertson (1 Jan 1998). "Zolpidem-associated hallucinations and serotonin reuptake inhibition: a possible interaction". Journal of Toxicology: Clinical Toxicology (بالإنجليزية). 36 (3): 195–203. DOI:10.3109/15563659809028939. ISSN:0731-3810. PMID:9656974. QID:Q74764031.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Simon Maskell; Munir Pirmohamed (4 Mar 2022). "A reference set of clinically relevant adverse drug-drug interactions". Scientific Data (بالإنجليزية). 9 (1). DOI:10.1038/S41597-022-01159-Y. ISSN:2052-4463. PMID:35246559. QID:Q123478206.
Drug Indications Extracted from FAERS، DOI:10.5281/ZENODO.1435999، QID:Q56863002
venlafaxine، معهد المعلوماتية الحيوية الأوروبي، QID:Q902623

wiley.com

accpjournals.onlinelibrary.wiley.com

https://accpjournals.onlinelibrary.wiley.com/doi/abs/10.1592/phco.24.6.621.34748. {{استشهاد ويب}}: |url= بحاجة لعنوان (مساعدة) والوسيط |title= غير موجود أو فارغ (من ويكي بيانات) (مساعدة)